Kera-FM 10% Solution is a topical formulation containing Minoxidil 10% w/v and Finasteride 0.1% w/v, indicated for the treatment of androgenetic alopecia in adult patients. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular blood flow and stimulating hair follicle proliferation. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor in hair follicle miniaturization and progressive hair loss. The combination of these active ingredients targets multiple pathogenic mechanisms underlying hair thinning and balding, providing a synergistic effect for improved efficacy compared to monotherapy. Kera-FM 10% Solution is applied topically to the affected scalp areas once or twice daily, as directed by a healthcare professional. It is essential to adhere to the recommended dosage and avoid contact with eyes or mucous membranes. Common adverse effects may include scalp irritation, itching, or erythema. Systemic absorption is minimal, but patients should be monitored for any signs of hypersensitivity or adverse reactions. This product is contraindicated in women who are pregnant or breastfeeding and in individuals with hypersensitivity to any component. Consultation with a healthcare provider is advised prior to initiation to ensure suitability and optimize therapeutic outcomes.